Naismith, R., Piccio, L., Lyons, J., Lauber, J., Tutlam, N., Parks, B., . . . Cross, A. (2010). Rituximab add-on therapy for breakthrough relapsing multiple sclerosis: A 52-week phase II trial [Image: see text] [Image: see text]. American Academy of Neurology.

Naismith, R.T., L. Piccio, J.A Lyons, J. Lauber, N.T Tutlam, B.J Parks, K. Trinkaus, S.K Song, und A.H Cross. Rituximab Add-on Therapy for Breakthrough Relapsing Multiple Sclerosis: A 52-week Phase II Trial [Image: See Text] [Image: See Text]. American Academy of Neurology, 2010.

Naismith, R.T., et al. Rituximab Add-on Therapy for Breakthrough Relapsing Multiple Sclerosis: A 52-week Phase II Trial [Image: See Text] [Image: See Text]. American Academy of Neurology, 2010.